Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-09-07 00:00:00 ET · period of report 2023-09-05 · accession 0001209191-23-048624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-07 | 2023-09-05 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $352.66 | -5,651 | 57.6K | -9% | -$1.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | S | D | 5,651 | $352.66 | 57,556 | D | — | — |